Understanding Dry Powder Inhalers Formulations: Role of Surface Polarity of lactose mixtures

Knowledge Center

Presentation / Oct 17, 2021

Understanding Dry Powder Inhalers Formulations: Role of Surface Polarity of lactose mixtures

Authors:

Ricardo Gonçalves

Source:

AAPS 2021

Track: Formulation and Delivery – Chemical
Rapid Fire: Role of Excipients in Formulation & Drug Product Development (CE)

��

Ricardo Gonçalves R&D Analytical Development | ��ɫAV

��

Presenting Author:��Ricardo Gonçalves��-��Analytical Scientist, R&D Analytical Development

��

Why do we use small lactose particles to improve Dry Powder Inhaler formulations? Why sieved and milled lactose particles present different properties? This presentation explores the role of surface energetics, measured using inverse gas chromatography, in the behavior of DPI formulations and the implication on their aerodynamic performance.

��

Also in the Knowledge Center

/ Jan 01, 2012

A hybrid approach to reach stringent low genotoxic impurity contents in active pharmaceutical ingredients: Combining molecularly imprinted polymers and organic solvent nanofiltration for removal of 1,3-diisopropylurea

Scientific Article

View

/ Jan 01, 1998

Pharmacokinetics, protein binding, and metabolic profile of 3H-icometasone enbutate following intravenous, oral, and intratracheal administrations to Sprague-Dawley rats

Scientific Article

View

��ɫAV

Browser not supported

Knowledge Center